Login to Your Account

Lexicon, Organon Enter $73M Protein, Antibody Agreement

By Karen Pihl-Carey

Wednesday, May 18, 2005
Signing its fourth major drug discovery alliance, Lexicon Genetics Inc. formed a $72.5 million collaboration with NV Organon to find five drug candidates for inflammatory disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription